Mesa Laboratories, Inc.
NASDAQ:MLABHardware, Equipment & Parts
-$0.15 today
- Market cap
- $774.56M
- Beta
- 0.93
- P/E (TTM)
- 78.3
- EPS (TTM)
- $1.21
- Dividend yield
- 0.68%
Volume 0.07M
Average 0.16M
MLAB Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Mesa Laboratories, Inc.NASDAQ: MLAB
Net Income · Q4 FY2026 · quarter ended Mar 2026
Net income grows, but more slowly than its trailing trend
Q4 FY2026 net income of $10.85M (cash outflow) rose 52.5% year over year, behind the +100.0% change in trailing-twelve-month net income. Over 3 fiscal years it compounded at +93.3% a year.
Context
- Net income amounted to 2.7% of revenue in FY2026, up 1.9 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 1 analysts of $63.91M (+852.2%) for the fiscal year ending Mar 2027, a step up from the +440.0% reported in FY2026.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$10.85M-398.8% QoQ
- Last fiscal yearMar 2026
- $6.71M+440.0% YoY
- LTMMar 2026
- $0+100.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +52.5% | +218.9% | +166.4 pp |
| 1 year | +440.0% | +852.2% | +412.2 pp |
| 3-year CAGR | +93.3% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2026
- 6.71M USD
- Year-over-year change
- +440.0%
- 4-year CAGR
- +37.6%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 6.71M | +440.0% |
| FY2025 | 2025-03-31 | (1.97M) | +99.2% |
| FY2024 | 2024-03-31 | (254.25M) | -27438.3% |
| FY2023 | 2023-03-31 | 930K | -50.3% |
| FY2022 | 2022-03-31 | 1.87M | — |
Net Income vs competitors
How MLAB compares with its peers on the latest reported figures
- MLAB's LTM Mar 2026 net income of $0 is the smallest of the 11 companies compared; the peer median is $125.09M.
- Its year-over-year change of +100.0% is the 3rd highest of 11, against a peer median of +8.8%.
- Net income amounts to 0.0% of revenue for MLAB, versus a peer median of 17.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $7.09B | +7.9% | -1.2% | 15.0% | |
| LTM Jul 2026 | $1.44B | +18.0% | -29.8% | 19.5% | |
| LTM Jun 2026 | $409.32M | +9.6% | +0.1% | 19.5% | |
| LTM Jul 2026 | $239.22M | -14.2% | -22.2% | 8.2% | |
| LTM Sep 2026 | $171.97M | +120.5% | -14.0% | 14.0% | |
| LTM Jun 2026 | $162.3M | +36.7% | — | 6.3% | |
| LTM Mar 2026 | $128.58M | -80.5% | +20.2% | 80.3% | |
| LTM Jun 2026 | $93.67M | -68.6% | — | 44.9% | |
| LTM Mar 2026 | $78.21M | +158.9% | -26.7% | 90.7% | |
| LTM Jun 2026 | $75.13M | -11.2% | -36.0% | 12.2% | |
| LTM Mar 2026 | $0 | +100.0% | +93.3% | 0.0% | |
| Peer median (excluding MLAB) | $125.09M | +8.8% | -18.1% | 17.2% | |
Competitors are the stored peer set for MLAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Net Income | 1.87M | 930K | (254.25M) | (1.97M) | 6.71M |
| Depreciation & Amortization | 25.07M | 33.13M | 31.57M | 24.53M | 23.27M |
| Deferred Income Tax | 128K | (3.49M) | (28.42M) | (72K) | (1.29M) |
| Stock-Based Compensation | 11.39M | 12.54M | 11.94M | 13.14M | 17.87M |
| Change in Working Capital | (7.19M) | (17.11M) | 5.97M | 6.9M | (4.99M) |
| Accounts Receivables | (6.75M) | (2.12M) | 4.94M | (2.93M) | (3.21M) |
| Inventory | (1.05M) | (10.18M) | 2.56M | 1.15M | (4.43M) |
| Accounts Payables | 1.37M | (1.55M) | (97K) | (388K) | (1.2M) |
| Other Working Capital | (765K) | (3.26M) | (1.43M) | 9.06M | 3.85M |
| Other Non-Cash Items | 7.96M | 1.99M | 277.32M | 4.28M | 1.26M |
| Operating Cash Flow | 39.22M | 27.98M | 44.13M | 46.81M | 42.83M |
| Capital Expenditures | (4.43M) | (4.54M) | (2.57M) | (4.5M) | (3.25M) |
| Acquisitions (Net) | (300.79M) | (4.95M) | (78.74M) | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | (250K) | 0 |
| Investing Cash Flow | (305.23M) | (9.49M) | (81.31M) | (4.5M) | (3.25M) |
| Debt Repayment | 49M | (36M) | 37.5M | (42.35M) | (26.75M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (3.34M) | (3.41M) | (3.45M) | (3.47M) | (3.52M) |
| Other Financing Activities | 6.92M | 6.08M | (1.22M) | 1.31M | (11.58M) |
| Financing Cash Flow | 52.58M | (33.33M) | 32.84M | (44.51M) | (41.85M) |
| Effect of Forex Changes | (1.09M) | (1.6M) | (359K) | 1.31M | 1.88M |
| Net Change in Cash | (214.52M) | (16.44M) | (4.7M) | (893K) | (393K) |
| Free Cash Flow | 34.79M | 23.44M | 41.57M | 42.31M | 39.58M |
Mesa Laboratories, Inc.
NASDAQ:MLAB
Intrinsic Alpha fair value
Locked
Current Price
$137.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.